Further research is needed to delineate the role of albumin levels in patients treated with ICIs in adjuvant settings and patients treated with ICI-based combinations, as well as the possible benefit of therapeutic approaches to improve hypoalbuminemia in ICI-treated patients. The gene discussed is ALB; the disease is Hypoalbuminemia.